Index | Control group (n = 68) | PRO group (n = 66) |
---|---|---|
Sex (Male/Female) | 35/33 | 35/31 |
Age (Year) | 60.16 ± 16.20 | 65.62 ± 18.18 |
BMI (kg/m2) | 23.06 ± 5.26 | 22.28 ± 3.66 |
Location of tumor | Â | Â |
  ascending colon | 15 | 15 |
  Transverse colon | 6 | 5 |
  Descending colon | 12 | 16 |
  Sigmoid colon | 15 | 11 |
  Rectum | 20 | 19 |
Time between onset of symptoms and hospital admission (d) | 50.28 ± 16.62 | 55.12 ± 18.26 |
Preoperative albumin (g/dL) | 38.26 ± 8.56 | 36.98 ± 6.96 |
Preoperative Hb (g/L) | 126.86 ± 32.06 | 116.22 ± 36.68 |
Creatinine (mg/dL) | 1.26 ± 0.28 | 1.20 ± 0.62 |
Operative time (min) | 186.28 ± 56.36 | 199.82 ± 55.98 |
Intra-operative blood loss (ml) | 336.26 ± 182.68 | 352.56 ± 169.26 |
Transfusion during operation (ml) | 308.12 ± 120.66 | 329.16 ± 130.58 |
Usage of supplemental albumin postoperation (g) | 22.38 ± 16.36 | 28.12 ± 20.98 |
Preoperation prepared time (d) | 6.12 ± 3.52 | 6.68 ± 2.98 |
Metronidazole (n) | 68 | 66 |
Penicillin (n) | 30 | 33 |
Ceftriaxone (n) | 38 | 33 |
ALT (U/L) | 35.68 ± 15.26 | 32.62 ± 18.86 |
AST (U/L) | 29.68 ± 16.56 | 28.22 ± 18.86 |